Precision Medicine Collaboration and Licensing Deals 2019-2024
16 janv. 2025 06h03 HE
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Precision Medicine Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a...
Silexion Therapeutics Announces Pricing of $5.0 Million Public Offering
15 janv. 2025 20h00 HE
|
Silexion Therapeutics Corp
Cayman Islands, January 15, 2025 -- Silexion Therapeutics Corp (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for...
Silexion Therapeutics Announces Additional Promising Preclinical Data for SIL-204, Demonstrating Impressive Synergy with First-Line Pancreatic Cancer Chemotherapies
15 janv. 2025 16h01 HE
|
Silexion Therapeutics Corp
Cayman Islands, January 15, 2025 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
Silexion Therapeutics to Present SIL-204 Data in KRAS-Driven Pancreatic Cancer at the 2025 ASCO Gastrointestinal Cancers Symposium
13 janv. 2025 07h50 HE
|
Silexion Therapeutics Corp
Cayman Islands, January 13, 2025 -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
Biosimulation Market Research Report 2024-2030: Expanding Applications in Defence, Industrial Bioprocessing, Nutraceuticals, and Agri-food Production
09 janv. 2025 07h38 HE
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Biosimulation Market (2024 Edition): Analysis By Type (Services, Software), By Application, By Deployment Model Outlook, By Region, By Country: Market...
PARP Inhibitor Biomarkers Market Review 2024 and Forecast 2025-2035: Breast Cancer Applications Lead in Revenue, While Ovarian Cancer Emerges as the Fastest-Growing Opportunity
09 janv. 2025 04h26 HE
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "PARP Inhibitor Biomarkers Market by Product, Service, Application, End User, and Region" report has been added to ResearchAndMarkets.com's offering....
Gene Panel Market Trends and Competition Analysis, Forecast to 2034 - Customized Gene Panels and Cancer Risk Assessments Lead the Charge in Gene Panel Market Expansion
08 janv. 2025 11h22 HE
|
Research and Markets
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Gene Panel Market by Product & Services, Techniques, Design, Application, End User, and Region" report has been added to ResearchAndMarkets.com's...
Precision Medicine in Oncology Collaboration and Licensing Deals Analysis Report 2024 with Directory of 821 Deals Signed Since 2016 by Company A-Z, Deal Type and Therapeutic Target
03 janv. 2025 10h59 HE
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report...
Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development
17 déc. 2024 06h30 HE
|
Silexion Therapeutics Corp
Cayman Islands, December 17, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
Cell Free DNA (cfDNA) Testing Market Outlook to 2028 & 2033 - Projected to Generate Revenues of $20.63 Billion by 2028, Fueled by Advances in Liquid Biopsy and Personalized Medicine
13 déc. 2024 09h49 HE
|
Research and Markets
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Cell Free DNA (cfDNA) Testing Market Outlook to 2028 & 2033" report has been added to ResearchAndMarkets.com's offering.The cell free DNA (cfDNA)...